AC Immune SA

US$2.23As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ACIUHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (16.52%)
Div yield —
ROE (80.66%)
Biotechnology
Beta (5Y) 1.61
PE TTM —
TSR TTM (34.02%)
Mkt cap US$221.7M
ROIC (48.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.46
10.46%
(37.81%)
Hold 12|6|11|6|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareFr
0.05
0.06
0.06
0.05
0.71%
15.84%
21.80%
13.90%
RevenueFr M
10.83
10.55
10.34
10.38
2.95%
1.34%
(1.03%)
(3.45%)
Peers (US$221.7M)
Cap (US$)
PE
161.1M
—
Capital
TTM
5Y
10Y
Leveragex
0.399
0.485
0.387
EBIT/Intx
3.100
1.576
1.566
Own earn%
886.24
(107.07)
(112.17)
Sh yield%
20.16
19.31
19.56
Owners
Insiders/Inst%
10.70
42.16
Short interest%
2.41
SBC / revenue%
0.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
10–22
$1 testx
0.2
Incr. ROIC%
3